Alistair Ellmer
Research Director Hanson Wade Intelligence
Seminars
Monday 3rd November 2025
ADC Toxicity: Exploring In Vivo Strategies & Clinical Topo1 Outcomes
12:00 pm
- Understanding state-of-play in NHP studies and implications for ADCs in the clinic
- Investigating top-line Topo1 asset toxicity data and considering impact on the ADC space
- Reviewing FIH trial adverse event data to help visualize the Topo1 toxicity landscape
